1 Scope of the Report 1
1.1 Market Introduction 1
1.2 Years Considered 2
1.3 Research Objectives 3
1.4 Market Research Methodology 3
1.5 Research Process and Data Source 5
1.6 Economic Indicators 6
1.7 Currency Considered 6

2 Executive Summary 7
2.1 World Market Overview 7
2.1.1 Global Continuous Glucose Monitoring Devices Sales 2016-2026 7
2.1.2 Continuous Glucose Monitoring Devices Sales CAGR by Region 8
2.2 Continuous Glucose Monitoring Devices Segment by Type 8
2.2.1 Based on Sensor 8
2.2.2 Based on Strip/Niddle 9
2.2.3 Others 9
2.3 Continuous Glucose Monitoring Devices Sales by Type 9
2.3.1 Global Continuous Glucose Monitoring Devices Sales Market Share by Type (2016-2021) 9
2.3.2 Global Continuous Glucose Monitoring Devices Revenue and Market Share by Type
(2016-2021) 10
2.3.3 Global Continuous Glucose Monitoring Devices Sale Price by Type (2016-2021) 12
2.4 Continuous Glucose Monitoring Devices Segment by Application 12
2.4.1 Hospitals & Clinics 12
2.4.2 Residential 13
2.4.3 Nursing Home 13
2.4.4 Others 13
2.5 Continuous Glucose Monitoring Devices Sales by Application 14
2.5.1 Global Continuous Glucose Monitoring Devices Sale Market Share by Application (2016-2021)
14
2.5.2 Global Continuous Glucose Monitoring Devices Revenue and Market Share by Application
(2016-2021) 14
2.5.3 Global Continuous Glucose Monitoring Devices Sale Price by Application (2016-2021) 16

3 Global Continuous Glucose Monitoring Devices by Company 17
3.1 Global Continuous Glucose Monitoring Devices Sales Market Share by Company 17
3.1.1 Global Continuous Glucose Monitoring Devices Sales by Company (2019-2021) 17
3.1.2 Global Continuous Glucose Monitoring Devices Sales Market Share by Company (2019-2021)
18

3.2 Global Continuous Glucose Monitoring Devices Revenue Market Share by Company 19
3.2.1 Global Continuous Glucose Monitoring Devices Revenue by Company (2019-2021) 19
3.2.2 Global Continuous Glucose Monitoring Devices Revenue Market Share by Company
(2019-2021) 20
3.3 Global Continuous Glucose Monitoring Devices Sale Price by Company 21
3.4 Key Manufacturers Continuous Glucose Monitoring Devices Producing Area Distribution, Sales
Area, Product Type 22
3.4.1 Key Manufacturers Continuous Glucose Monitoring Devices Product Location Distribution 22
3.4.2 Players Continuous Glucose Monitoring Devices Products Offered 22
3.5 Market Concentration Rate Analysis 23
3.5.1 Competition Landscape Analysis 23
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) 23
3.6 New Products and Potential Entrants 23
3.7 Mergers & Acquisitions, Expansion 24

4 Continuous Glucose Monitoring Devices by Region 25
4.1 Global Continuous Glucose Monitoring Devices by Region 25
4.1.1 Global Continuous Glucose Monitoring Devices Sales by Region 25
4.1.2 Global Continuous Glucose Monitoring Devices Revenue by Region 25
4.2 Americas Continuous Glucose Monitoring Devices Sales Growth 27
4.3 APAC Continuous Glucose Monitoring Devices Sales Growth 28
4.4 Europe Continuous Glucose Monitoring Devices Sales Growth 28
4.5 Middle East & Africa Continuous Glucose Monitoring Devices Sales Growth 28

5 Americas 29
5.1 Americas Continuous Glucose Monitoring Devices Sales by Country 29
5.1.1 Americas Continuous Glucose Monitoring Devices Sales by Country (2016-2021) 29
5.1.2 Americas Continuous Glucose Monitoring Devices Revenue by Country (2016-2021) 30
5.2 Americas Continuous Glucose Monitoring Devices Sales by Type 31
5.3 Americas Continuous Glucose Monitoring Devices Sales by Application 31
5.4 United States 32
5.5 Canada 32
5.6 Mexico 33
5.7 Brazil 33

6 APAC 34
6.1 APAC Continuous Glucose Monitoring Devices Sales by Region 34
6.1.1 APAC Continuous Glucose Monitoring Devices Sales by Region (2016-2021) 34
6.1.2 APAC Continuous Glucose Monitoring Devices Revenue by Region (2016-2021) 34
6.2 APAC Continuous Glucose Monitoring Devices Sales by Type 35
6.3 APAC Continuous Glucose Monitoring Devices Sales by Application 36
6.4 China 36
6.5 Japan 37
6.6 Korea 37
6.7 Southeast Asia 37
6.8 India 37
6.9 Australia 37

7 Europe 38
7.1 Europe Continuous Glucose Monitoring Devices by Country 38
7.1.1 Europe Continuous Glucose Monitoring Devices Sales by Country (2016-2021) 38
7.1.2 Europe Continuous Glucose Monitoring Devices Revenue by Country (2016-2021) 39
7.2 Europe Continuous Glucose Monitoring Devices Sales by Type 39
7.3 Europe Continuous Glucose Monitoring Devices Sales by Application 40
7.4 Germany 40
7.5 France 40
7.6 UK 40
7.7 Italy 41
7.8 Russia 41

8 Middle East & Africa 42
8.1 Middle East & Africa Continuous Glucose Monitoring Devices by Country 42
8.1.1 Middle East & Africa Continuous Glucose Monitoring Devices Sales by Country (2016-2021)42
8.1.2 Middle East & Africa Continuous Glucose Monitoring Devices Revenue by Country (2016-2021)
42
8.2 Middle East & Africa Continuous Glucose Monitoring Devices Sales by Type 42
8.3 Middle East & Africa Continuous Glucose Monitoring Devices Sales by Application 43
8.4 Egypt 44
8.5 South Africa 44
8.6 Israel 44
8.7 Turkey 44
8.8 GCC Countries 44

9 Market Drivers, Challenges and Trends 45
9.1 Market Drivers and Impact 45
9.1.1 Growing Demand from Key Regions 45
9.1.2 Growing Demand from Key Application and Potential Industries 45
9.2 Market Challenges and Impact 45
9.3 Market Trends 45

10 Marketing, Distributors and Customer 47
10.1 Sales Channel 47
10.1.1 Direct Channels 47
10.1.2 Indirect Channels 47
10.2 Continuous Glucose Monitoring Devices Distributors 49
10.3 Continuous Glucose Monitoring Devices Customer 50

11 Global Continuous Glucose Monitoring Devices Market Forecast 51
11.1 Global Continuous Glucose Monitoring Devices Forecast by Region 51
11.1.1 Global Continuous Glucose Monitoring Devices Forecast by Region (2021-2026) 51
11.1.2 Global Continuous Glucose Monitoring Devices Revenue Forecast by Region (2021-2026) 51
11.2 Americas Forecast by Country 52
11.3 APAC Forecast by Region 52
11.4 Europe Forecast by Country 53
11.5 Middle East & Africa Forecast by Country 53
11.6 Global Continuous Glucose Monitoring Devices Forecast by Type 54
11.7 Global Continuous Glucose Monitoring Devices Forecast by Application 55

12 Key Players Analysis 56
12.1 Abbott Laboratories 56
12.1.1 Abbott Laboratories Company Information 56
12.1.2 Abbott Laboratories Continuous Glucose Monitoring Devices Product Offered 56
12.1.3 Abbott Laboratories Continuous Glucose Monitoring Devices Sales, Revenue, Price and Gross
Margin (2019-2021) 56
12.1.4 Abbott Laboratories Main Business Overview 57
12.1.5 Abbott Laboratories Latest Developments 57
12.2 Echo Therapeutics 57
12.2.1 Echo Therapeutics Company Information 57
12.2.2 Echo Therapeutics Continuous Glucose Monitoring Devices Product Offered 57
12.2.3 Echo Therapeutics Continuous Glucose Monitoring Devices Sales, Revenue, Price and Gross
Margin (2019-2021) 58
12.2.4 Echo Therapeutics Main Business Overview 58
12.2.5 Echo Therapeutics Latest Developments 58
12.3 Dexcom 59
12.3.1 Dexcom Company Information 59
12.3.2 Dexcom Continuous Glucose Monitoring Devices Product Offered 59
12.3.3 Dexcom Continuous Glucose Monitoring Devices Sales, Revenue, Price and Gross Margin
(2019-2021) 59
12.3.4 Dexcom Main Business Overview 60
12.3.5 Dexcom Latest Developments 60
12.4 GlySens Incorporated 60
12.4.1 GlySens Incorporated Company Information 60
12.4.2 GlySens Incorporated Continuous Glucose Monitoring Devices Product Offered 61
12.4.3 GlySens Incorporated Continuous Glucose Monitoring Devices Sales, Revenue, Price and
Gross Margin (2019-2021) 61
12.4.4 GlySens Incorporated Main Business Overview 61
12.4.5 GlySens Incorporated Latest Developments 61
12.5 Medtronic 62
12.5.1 Medtronic Company Information 62
12.5.2 Medtronic Continuous Glucose Monitoring Devices Product Offered 62
12.5.3 Medtronic Continuous Glucose Monitoring Devices Sales, Revenue, Price and Gross Margin
(2019-2021) 62
12.5.4 Medtronic Main Business Overview 63
12.5.5 Medtronic Latest Developments 63
12.6 Senseonics Holdings 63
12.6.1 Senseonics Holdings Company Information 63
12.6.2 Senseonics Holdings Continuous Glucose Monitoring Devices Product Offered 64
12.6.3 Senseonics Holdings Continuous Glucose Monitoring Devices Sales, Revenue, Price and Gross
Margin (2019-2021) 64
12.6.4 Senseonics Holdings Main Business Overview 64
12.6.5 Senseonics Holdings Latest Developments 64
12.7 Johnson & Johnson 65
12.7.1 Johnson & Johnson Company Information 65
12.7.2 Johnson & Johnson Continuous Glucose Monitoring Devices Product Offered 65
12.7.3 Johnson & Johnson Continuous Glucose Monitoring Devices Sales, Revenue, Price and Gross
Margin (2019-2021) 65
12.7.4 Johnson & Johnson Main Business Overview 66
12.7.5 Johnson & Johnson Latest Developments 66
12.8 Roche 66
12.8.1 Roche Company Information 66
12.8.2 Roche Continuous Glucose Monitoring Devices Product Offered 66
12.8.3 Roche Continuous Glucose Monitoring Devices Sales, Revenue, Price and Gross Margin
(2019-2021) 67
12.8.4 Roche Main Business Overview 67
12.8.5 Roche Latest Developments 67
12.9 AgaMatrix 68
12.9.1 AgaMatrix Company Information 68
12.9.2 AgaMatrix Continuous Glucose Monitoring Devices Product Offered 68
12.9.3 AgaMatrix Continuous Glucose Monitoring Devices Sales, Revenue, Price and Gross Margin
(2019-2021) 68
12.9.4 AgaMatrix Main Business Overview 69
12.9.5 AgaMatrix Latest Developments 69
12.10 Glucovation 69
12.10.1 Glucovation Company Information 69
12.10.2 Glucovation Continuous Glucose Monitoring Devices Product Offered 69
12.10.3 Glucovation Continuous Glucose Monitoring Devices Sales, Revenue, Price and Gross
Margin (2019-2021) 70
12.10.4 Glucovation Main Business Overview 70
12.10.5 Glucovation Latest Developments 70
12.11 GlySure 71
12.11.1 GlySure Company Information 71
12.11.2 GlySure Continuous Glucose Monitoring Devices Product Offered 71
12.11.3 GlySure Continuous Glucose Monitoring Devices Sales, Revenue, Price and Gross Margin
(2019-2021) 71
12.11.4 GlySure Main Business Overview 72
12.11.5 GlySure Latest Developments 72
12.12 Arkray USA 72
12.12.1 Arkray USA Company Information 72
12.12.2 Arkray USA Continuous Glucose Monitoring Devices Product Offered 72
12.12.3 Arkray USA Continuous Glucose Monitoring Devices Sales, Revenue, Price and Gross Margin
(2019-2021) 73
12.12.4 Arkray USA Main Business Overview 73
12.12.5 Arkray USA Latest Developments 73
12.13 OrSense 74
12.13.1 OrSense Company Information 74
12.13.2 OrSense Continuous Glucose Monitoring Devices Product Offered 74
12.13.3 OrSense Continuous Glucose Monitoring Devices Sales, Revenue, Price and Gross Margin
(2019-2021) 74
12.13.4 OrSense Main Business Overview 75
12.13.5 OrSense Latest Developments 75
12.14 Contour(Ascensia) 75
12.14.1 Contour(Ascensia) Company Information 75
12.14.2 Contour(Ascensia) Continuous Glucose Monitoring Devices Product Offered 75
12.14.3 Contour(Ascensia) Continuous Glucose Monitoring Devices Sales, Revenue, Price and Gross
Margin (2019-2021) 76
12.14.4 Contour(Ascensia) Main Business Overview 76
12.14.5 Contour(Ascensia) Latest Developments 76
12.15 AccuChek 77
12.15.1 AccuChek Company Information 77
12.15.2 AccuChek Continuous Glucose Monitoring Devices Product Offered 77
12.15.3 AccuChek Continuous Glucose Monitoring Devices Sales, Revenue, Price and Gross Margin
(2019-2021) 77
12.15.4 AccuChek Main Business Overview 78
12.15.5 AccuChek Latest Developments 78
12.16 AUVON 78
12.16.1 AUVON Company Information 78
12.16.2 AUVON Continuous Glucose Monitoring Devices Product Offered 78
12.16.3 AUVON Continuous Glucose Monitoring Devices Sales, Revenue, Price and Gross Margin
(2019-2021) 79
12.16.4 AUVON Main Business Overview 79
12.16.5 AUVON Latest Developments 79
12.17 One Touch 80
12.17.1 One Touch Company Information 80
12.17.2 One Touch Continuous Glucose Monitoring Devices Product Offered 80
12.17.3 One Touch Continuous Glucose Monitoring Devices Sales, Revenue, Price and Gross Margin
(2019-2021) 80
12.17.4 One Touch Main Business Overview 81
12.17.5 One Touch Latest Developments 81
12.18 Prodigy 81
12.18.1 Prodigy Company Information 81
12.18.2 Prodigy Continuous Glucose Monitoring Devices Product Offered 81
12.18.3 Prodigy Continuous Glucose Monitoring Devices Sales, Revenue, Price and Gross Margin
(2019-2021) 82
12.18.4 Prodigy Main Business Overview 82
12.18.5 Prodigy Latest Developments 82

13 Research Findings and Conclusion 83